Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
388
datasets available to search
ShareScore release 0.9.0
Dataset results
388 results for “immune checkpoint inhibitors”
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
ClinicalTrials.gov study NCT06349642. IPD Sharing: NO. Countries: 1. Publications: 1.
Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor
ClinicalTrials.gov study NCT06218069. IPD Sharing: NO. Countries: 2. Publications: 11.
Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05699915. IPD Sharing: NO. Countries: 1. Publications: 1.
SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs
ClinicalTrials.gov study NCT06522048. IPD Sharing: NO. Countries: 1. Publications: 5.
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT06470997. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Immune Checkpoint Inhibitors and Atherosclerotic Plaque Volume
ClinicalTrials.gov study NCT04430712. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor
ClinicalTrials.gov study NCT03590808. IPD Sharing: NO. Countries: 1. Publications: 9.
Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers
ClinicalTrials.gov study NCT04196465. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04294771. IPD Sharing: NO. Countries: 1. Publications: 7.
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05334329. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma
ClinicalTrials.gov study NCT02723006. IPD Sharing: YES. Countries: 1. Publications: 0.
Abatacept in Immune Checkpoint Inhibitor Myocarditis
ClinicalTrials.gov study NCT05335928. IPD Sharing: NO. Countries: 2. Publications: 1.
Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes
ClinicalTrials.gov study NCT07321067. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Immune Checkpoint Inhibitors Nephrotoxicity
ClinicalTrials.gov study NCT04902846. IPD Sharing: NO. Countries: 1. Publications: 1.
ePRO-based Model of Care to Manage and Monitoring Symptoms of Cancer Patients Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05530187. IPD Sharing: NO. Countries: 1. Publications: 2.
Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04977791. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer
ClinicalTrials.gov study NCT04822103. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma
ClinicalTrials.gov study NCT03293784. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction
ClinicalTrials.gov study NCT03492242. IPD Sharing: UNDECIDED. Countries: 1. Publications: 12.
Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05609695. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.